Journal article
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- Abstract:
-
Background The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effects of these vaccines is an urgent requirement. The aim of our study was to investigate the association between the mass roll-out of the first doses of these COVID-19 vaccines an...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Supplementary materials, 479.4KB)
-
(Version of record, 700.9KB)
-
- Publisher copy:
- 10.1016/S0140-6736(21)00677-2
Authors
Funding
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Journal website
- Volume:
- 397
- Issue:
- 10285
- Pages:
- 1646-1657
- Publication date:
- 2021-04-23
- Acceptance date:
- 2021-03-19
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1168788
- Local pid:
- pubs:1168788
- Deposit date:
- 2021-03-19
Terms of use
- Copyright holder:
- Vasileiou et al.
- Copyright date:
- 2021
- Rights statement:
- © 2021 The Authors. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record